Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.

@article{Riquelme2003SaccharomycesCF,
  title={Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.},
  author={Arnoldo J Riquelme and Mario A Calvo and Ana Mar{\'i}a Guzm{\'a}n and Mar{\'i}a Soledad Depix and Patr{\'i}cia Petromili Nordi Sasso Garcia and Carlos Eduardo Aucique Perez and Marco Arrese and Jaime A. Labarca},
  journal={Journal of clinical gastroenterology},
  year={2003},
  volume={36 1},
  pages={41-3}
}
Saccharomyces cerevisiae is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii Molecular typing confirmed clonality in isolate strains from patients and the capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use. 

From This Paper

Topics from this paper.
50 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 50 extracted citations

Similar Papers

Loading similar papers…